The campaign draws on the familiar experiences of Nigerians who manage demanding work schedules, business responsibilities, family commitments and multiple sources of income.

Through the message, the company seeks to communicate that determination and hard work should not mean ignoring the body's need for rest and care.

The campaign also forms part of CHI Pharmaceuticals' efforts to strengthen the visibility of Alieve within Nigeria's healthcare market.

Chief Marketing Officer of TGI Group, Probal Bhattacharya, said the campaign reflects how people often push themselves through demanding routines without recognising their physical limits until discomfort interrupts their activities.

He described the message as a reminder that people are not machines and that personal wellbeing should remain important even while pursuing professional and personal goals.

Alieve contains ibuprofen, and its listed formulations include a 100mg/5mL oral suspension and 200mg and 400mg tablets.

The National Agency for Food and Drug Administration and Control (NAFDAC) registry lists the three formulations under CHI Pharmaceutical Limited, with active registration status.

The campaign's central message, “Man No Be Machine,” is intended to connect with the realities of everyday Nigerian life while drawing attention to the company's product range.

The initiative adds to CHI Pharmaceuticals' brand communication activities and highlights the growing role of consumer-focused campaigns in the country's healthcare and pharmaceutical industry.

Reporting by TalkNaijaMedia